From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025
And what you've done in three years is just extraordinary
1500 mg Falcon Pharma Booster Injection Request Callback 3600 / Vial Get Latest Price Product Brochure Minimum order quantity: 100 Vial It is used for the treatment of many fungal infections like Cryptococcal meningitis (fungal infection in the brain) and Coccidioidomycosis (a disease of the lungs)
Simultaneously, these drugs suppress glucagon secretion, which prevents the liver from releasing excess glucose into the bloodstream
High concentrations of resveratrol may inhibit mitochondrial complex I, while synthetic activators like SRT2104 require high doses due to poor liver targeting, increasing oxidative stress risk in extrahepatic tissues
